Efficacy and Safety of PD-L1 Inhibitors plus Chemotherapy versus Chemotherapy Alone in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Retrospective Real-World Study.
Jingjing QuFarhin Shaheed KalyaniQian ShenGuangdie YangTianli ChengLi LiuJianya ZhouJian-Ying ZhouPublished in: Journal of oncology (2022)
This study shows that adding PD-L1 inhibitors to chemotherapy can significantly improve PFS and OS in patients with ES-SCLC and demonstrates its safety without additional AEs.